Spry2 does not directly modulate Raf-1 kinase activity in v-Ha-ras-transformed NIH 3T3 fibroblasts
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Sprouty (Spry) proteins have previously been suggested as negative regulators of the MAPK pathway through interaction with Raf-1. However, the molecular basis of this inhibition has not been elucidated. In this study, we used cells expressing FLAGtagged Raf-1 with point mutations at known phosphorylation sites to reveal that activation of Raf-1 mutants does not correlate with their degree of interaction with Spry2. The association of Raf-1 with Spry2 in intact cells was further corroborated by immunofluorescence colocalization. Additionally, there was no significant change observed in the strength of interaction between Raf-1 mutants and Spry2 after paclitaxel treatment despite differences in the activation levels of these mutants. Thus,our study provides the evidence that Spry2 does not directly regulate Raf-1 kinase activity, but instead acts as a scaffolding protein that assists interactions between Raf-1 kinase and its direct regulators.
Abstract
Sprouty (Spry) proteins have previously been suggested as negative regulators of the MAPK pathway through interaction with Raf-1. However, the molecular basis of this inhibition has not been elucidated. In this study, we used cells expressing FLAGtagged Raf-1 with point mutations at known phosphorylation sites to reveal that activation of Raf-1 mutants does not correlate with their degree of interaction with Spry2. The association of Raf-1 with Spry2 in intact cells was further corroborated by immunofluorescence colocalization. Additionally, there was no significant change observed in the strength of interaction between Raf-1 mutants and Spry2 after paclitaxel treatment despite differences in the activation levels of these mutants. Thus,our study provides the evidence that Spry2 does not directly regulate Raf-1 kinase activity, but instead acts as a scaffolding protein that assists interactions between Raf-1 kinase and its direct regulators.
참고문헌 (25)
- Sasaki, A., "Mammalian Sprouty4 suppresses Rasindependent ERK activation by binding to Raf1", Nat. Cell. Biol., 5, pp.427~432 (2003)
- Yusoff, P., "Sprouty2 inhibits the Ras", MAP Kinase pathway by inhibiting the activation of Raf, 2002, pp.277, 3195~3201
- Lito, P., "Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogenetransformed human fibroblasts", J. Biol. Chem., 283, pp.2002~2009 (2008)
- Kim, H. J., "Modulation of signalling by Sprouty: a developing story", Nat. Rev. Mol. Cell Biol., 5, pp.441~450 (2004)
- Mason, J. M., "Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling", Trends Cell Biol., 16, pp.45~54 (2006)
- Kolch, W., "Meaningful relationships: the regulation of the Ras", Raf, ERK pathway by protein interactions, pp.Biochem. J., 2000[DOI]
- Marshall, M. S., "Ras target proteins in eucaryotic cells", FASEB J., 9, pp.1311~1318 (1995)
- Luo, Z., "An intact Raf zinc finger is required for optimal binding to processed Ras and for Ras-dependent Raf activation in situ", Mol. Cell. Biol., 17, pp.46~53 (1997)
- Dhillon, A. S., "Untying the regulation of the Raf-1 kinase", Arch. Biochem. Biophys., 404, pp.3~9 (2002)
- Diaz, B., "Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling", Mol. Cell. Biol., 17, pp.4509~4516 (1997)
- Fabian, J. R., "Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase", Mol. Cell. Biol., 13, pp.7170~7179 (1993)
- Kolch, W., "Protein kinase C alpha activates Raf-1 by direct phosphorylation", Nature, 364, pp.249~252 (1993)
- Reich, A., "Sprouty is a general inhibitor of receptor tyrosine kinase signaling", Development, 126, pp.4139~4147 (1999)
- Lee, M., "Raf-1 kinase activation is uncoupled from downstream MEK", ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2, 2006, pp.350, 450~456
- Blagosklonny, M. V., "Raf-1", bcl-2 phosphorylation: a step from microtubule damage to cell death, 1997, pp.57, 130~135
- Cheung, H. W., "Id-1-induced Raf", MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells, 2004, pp.25, 881~887
- Improta-Brears, T., "Mutational analysis of Raf-1 cysteine rich domain: requirement for a cluster of basic aminoacids for interaction with phosphatidylserine", J. Cell Biochem., 198, pp.171~178 (1999)
- Ahn, J. H., "The enhancement of Raf-1 kinase activity by knockdown of Spry2 is associated with high sensitivity to paclitaxel in v-Ha-ras-transformed NIH 3T3 fibroblasts", Mol. Cell. Biochem., 332, pp.189~197 (2009)
- Lee, A. C., "Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species", J. Biol. Chem., 274, pp.7936~7940 (1999)
- Mason, J. M., "Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop", Mol. Biol. Cell, 15, pp.2176~2188 (2004)
- Lao, D. H., "Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation", J. Biol. Chem., 282, pp.9117~9126 (2007)
- Impagnatiello, M. A., "Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells", J. Cell. Biol., 152, pp.1087~1098 (2001)
- Chandramouli, S., "Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling", J. Biol. Chem., 283, pp.1679~1691 (2008)
- Li, X., "Sprouty: a controversial role in receptor tyrosine kinase signalling pathways", Biochem. Soc. Trans., 31, pp.1445~1446 (2003)
- Yuk Pheel Park, "Induction of Mac-2BP by nerve growth factor is regulated by the PI3K", Akt, BMB reports, pp.2008, 41(11)[DOI]